APhA recognizes Touro College with immunization award
NEW YORK The American Pharmacist Association has given its Immunization Champion Award to a school of pharmacy in New York City.
Touro College of Pharmacy, in the Harlem neighborhood, was among more than 100 nominees competing for the ward, which receives support from Novartis Vaccines & Diagnostics. The award program will take place at the APhA’s annual meeting in Washington from March 12 to 15.
“In December 2009, pharmacists in New York state were approved to provide immunizations to adults 18 and older,” college dean Stuart Feldman said in a statement. “Since then, the College of Pharmacy has been meeting its community’s immunization needs by working with partners to set up neighborhood vaccination sites that are accessible and where people feel comfortable visiting.”
The award is meant to recognize pharmacists’ contributions in improving vaccination rates. The APhA award went to Touro for its partnership with the New York City Department of Health and Mental Hygiene and the New York Academy of Medicine, where faculty, staff and students provided more than 2,000 influenza immunizations in the Harlem community during the last flu season. Pharmacists from the college also immunized more than 600 people during Harlem Immunization Week, which took place between Oct. 17 and 23.
Pfizer may buy Ratiopharm
NEW YORK It appears that Pfizer has changed its mind a second time about buying Ratiopharm.
According to published reports, Pfizer has renewed its offer for the German generic drug maker, for $4 billion. That pits the world’s largest drug maker against generic drug makers Teva Pharmaceutical Industries and Actavis.
Pfizer has been on a hunt for opportunities lately, most notably with its acquisition of Wyeth, as it faces patent expirations on such high-selling drugs as the cholesterol medication Lipitor (atorvastatin).
Walgreens completes acquisition of SpecialtyScripts
DEERFIELD, Ill. Walgreens has completed its acquisition of prescription files from Cardinal Health subsidiary SpecialtyScripts, based in Fall River, Mass., Walgreens announced Wednesday.
Founded in 2002, SpecialtyScripts niche is in providing specialty pharmacy services for such chronic illnesses and complex diseases as hepatitis C, psoriasis, rheumatoid arthritis and oral oncology.
Walgreens said the acquisition would allow Walgreens Specialty Pharmacy to scale the operations of its existing locations. Financial terms of the deal were not disclosed.
“We’re excited about our acquisition of SpecialtyScripts and see it as an opportunity to grow our specialty pharmacy business through additional preferred payer agreements,” Walgreens Specialty Pharmacy EVP and Walgreens divisional VP Michael Nameth said in a statement. “It’s a good fit for us because SpecialtyScripts has a similar client base, and we share a commitment to providing patients and customers with quality care and exceptional service.”